BRD9通过调节染色体状态来决定造血干细胞的细胞命运
Muran Xiao1,2, Shinji Kondo3,4, Masaki Nomura1,5
1Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
Nature communications
|December 15, 2023
概括
非正规的BAF (ncBAF) 综合体,通过其BRD9成分,对于造血干细胞 (HSC) 的命运至关重要. 失去BRD9会改变染色体的可访问性,影响正常和恶性血液形成中的髓状细胞和B细胞发育.
科学领域:
- 细胞和分子生物学 细胞和分子生物学
- 表观遗传学和基因调控
- 血液形成和干细胞生物学
背景情况:
- 依赖ATP的染色体重塑SWI/SNF复合体包括正规BAF (cBAF),多博BAF (PBAF) 和非正规BAF (ncBAF) 的子复合体.
- 虽然在各种细胞类型中已知cBAF和PBAF的功能,但ncBAF在造血干细胞 (HSC) 中的作用仍然未被探索.
- 一个重要的ncBAF成分BRD9在癌症中表现出干扰的表达,包括造血性疾病.
研究的目的:
- 研究BRD9在正常和恶性HSC中的作用.
- 阐明ncBAF通过哪些机制影响HSC中的细胞命运规范.
主要方法:
- 评估了BRD9损失对HSC染色体可访问性和基因表达的影响.
- 研究了BRD9与CTCF的局部化及其对染色质结构的影响.
- 分析了BRD9改变对髓状细胞和B细胞发育的影响.
主要成果:
- BRD9 损失提高了染色质的可访问性,导致骨髓状细胞谱系倾斜和B 细胞发育受损.
- BRD9 损失增加了 CTCF 染色质的招募,改变了拓学关联域内的染色质状态和髓状基因表达.
- 这些发现凸显了ncBAF在HSC命运规范中的关键作用.
结论:
- ncBAF对于通过3D基因组调节来确定HSC中的细胞命运至关重要.
- ncBAF在正常和恶性血液形成中起着重要作用.
- 在HSC中,BRD9是染色质可访问性和谱系承诺的关键调节者.
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Maintenance of the ES Cell State
2.2K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K
Chromatin Structure Regulates pre-mRNA Processing
7.0K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
7.0K
Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K


